Health Awareness Inc | Jupiter, FL

Research site

(Unclaimed)

Location

500 University Boulevard, Suite 208, Jupiter, Florida, United States of America

Site insights

Top conditions

Top treatments

Buprenorphine

Diclofenac Sodium Gel

Estradiol

Vibegron

Plecanatide

fezolinetant

Canakinumab

HYD

Hydrocodone Bitartrate

Lansoprazole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 81 total trials

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting

COVID-19

Biological: mRNA-1273.222

Biological: mRNA-1283.222

Locations recently updated

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight

This study is open to adults who are at least 18 years old and have* presumed or confirmed NASH together with overweight or obesity and* a body mass...

Enrolling

Non-Alcoholic SteatoHepatitis (NASH)

Obesity

Drug: Survodutide

Drug: Placebo

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (COVID-19)

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...

Active, not recruiting

COVID-19

Biological: NVX-CoV2601 (5μg)

Biological: NVX-CoV2601 (35μg)

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

The objective of the study is to evaluate the safety, tolerability and immunogenicity of a single injection of VAX-31 at 3 dose levels compared to Pr...

Active, not recruiting

Pneumococcal Vaccines

Biological: 20 valent pneumococcal conjugate vaccine

Biological: 31 valent pneumococcal conjugate vaccine

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting

Influenza, Human

Biological: licensed QIV2

Biological: Investigational aQIVc